Several miRs that exhibit altered expression in ESCC are able to regulate the activity of either NRF2 or KEAP1, and may provide an alternative route by which the expression of NRF2-target genes can be enhanced in ESCC tumours lacking NFE2L2 mutations. Here, NFE2L2 is linked to esophageal squamous cell carcinoma.